MD Medical Group opens new clinic in Kazan
MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has opened a new clinic in Kazan. Investment in the project totalled around 60 million roubles.
Mother&Child Kazan has a total area of 677 sq m. The clinic offers a wide range of services for women such as IVF, ultrasound, minor gynaecological operations in the day-patient centre and OBGYN, as well as medical services for all family members including cardiology, genetics, urology, endocrinology, neurology, etc.
The clinic has annual capacity for up to 400 minor gynaecological operations; up to 1,000 IVF cycles, including under the Mandatory Health Insurance (MHI) programme; and more than 50,000 out-patient treatments per year.
The Kazan clinic has been created in line with MD Medical Group’s customary high standards of medical care and is fitted with world-class equipment produced by Karl Storz, GE, Olympus and Origio.
Mark Kurtser, CEO of MD Medical Group, said:
“We continue to implement our strategy aimed at expanding the Company’s footprint in the largest Russian regions. Today, we are opening our new clinic in the million-plus city of Kazan – dynamically developing capital of the Republic of Tatarstan, a federal subject of Russia. In total, the Group now operates 40 medical centres of various sizes across Russia.“The new clinic in Kazan will focus on providing healthcare services for women, including IVF under the MHI programme. At the same time, we will offer a number of other medical services for all family members.“We see great potential in Tatarstan, where considerable emphasis is placed on developing the local healthcare system. By opening our first clinic here, we will demonstrate our capabilities in healthcare to the residents in the city and the wider region, helping to increase our brand recognition in anticipation of the construction of a large multi-disciplinary hospital in Kazan.”
For further information please contact:
|
Investors |
Media |
|
Dmitry Yakushkin
MD Medical Group Investments Plc
Tel: +7 495 331 4120 d.yakushkin@mcclinics.ru |
EM
Tom Blackwell: +7 919 102 9064 Sergii Pershyn: +1 929 855 8188
|
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 40 modern healthcare facilities, including 5 hospitals and 35 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, and Kazan.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.